Sara Ashley O'Brien's C3 piece in today's WSJ profiles a generation of young men chasing physical perfection through the gray-market peptide trade. Trevor Larcom, 22, of Melbourne, Florida, has been injecting growth-hormone peptides and a tanning compound called Melanotan II on and off for seven months. He paid $65 for a three-week supply of one stack. He communicates with sellers on WhatsApp. He says he's seen kids as young as 13 and 14 talking about peptides online. Nathan Carranza, an 18-year-old senior in the Bay Area, paid $90 for a one-to-two-month supply of retatrutide — an Eli Lilly weight-loss compound still in clinical trials.
The Medical Case Against This
Dr. Adda Grimberg, pediatric endocrinologist at Children's Hospital of Philadelphia, told the Journal that growth-hormone peptides in still-developing bodies can cause disproportionate growth of the hands, feet, jaw, and tongue. The FDA has issued warning letters to peptide sellers and notes that contamination and dosing inconsistency are uncontrolled risks. Several users in O'Brien's reporting acknowledge they know about melanoma risk from MT-II and are doing it anyway.
The Financial Case Nobody's Writing About
A typical "stack" runs $200–$400 a month on a recurring basis. A 22-year-old who runs the protocol for three years spends $7,000–$14,000 on a category of drug with no FDA approval, no insurance reimbursement, and a non-zero probability of a cancer diagnosis on the back end. The opportunity cost on the same dollars in a Roth IRA at age 22, compounded to age 65 at 7%, is roughly $115,000 on the high end. That is the down payment on a house. That is two years of nursing home.
Run the same math at age 18. A high-school senior funding $400 a month of peptides could instead be funding the $583 monthly maximum on a Roth IRA. At 8% annualized over 47 years, that contribution alone (no employer match, no other savings) compounds to roughly $2.8 million at age 65. The peptide stack buys a jawline for a year. The Roth IRA buys retirement.
How To Find It On The Credit Card Statement
You won't. Peptides arrive in unmarked envelopes, get paid for via international wire on WhatsApp, and almost never show up on a credit-card statement with a recognizable merchant name. The signals are different: an unusually fit-looking kid, recovery from gym sessions that no 18-year-old should recover from that fast, a sudden interest in needles and small refrigerated parcels arriving at the house. The conversation is uncomfortable. The cost of not having it is higher.
Have The Conversation This Weekend
If your son is in the gym four days a week and his recovery seems remarkable, ask the question. The conversation we have with parents: the Roth IRA you opened for your kid at 18 with the first $7,000 of summer-job money does more for his long-term life than any peptide stack does. That is the comparison worth making at the dinner table. We have a one-page custodial-Roth checklist for parents who want to open one this month.